A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-491 in Korean Subjects With Essential Hypertension
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003327/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the antihypertensive effect of azilsartan medoxomil versus placebo in Korean adults with essential hypertension.
本研究旨在对比阿齐沙坦酯（azilsartan medoxomil）与安慰剂在韩国原发性高血压成人患者中的降压疗效。
提供机构：
Vivli
创建时间：
2019-02-06
